NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating DaVita Inc. (NYSE:DVA) ("DaVita" or the
Investigation comes after a October 20, 2026 report concerning DaVita Inc.; shareholders who suffered losses may have claims to recover themInvestors who suffered losses on DaVita Inc. ("DaVita" or the
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. ("DaVita" or the "Company") (NYSE:DVA). Such investors are advised to contact
DENVER, Nov. 3, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) today announced that its Chief Financial Officer, Joel Ackerman, and its Group Vice President of Investor Relations, Nic Eliason, will participate in fireside
Investigation centers on the October 20, 2026 news about DaVita Inc.; investors with losses may have potential claims to recover themDaVita Inc. ("DaVita" or the "Company") investors who lost money may
DENVER, Oct. 29, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter ended September 30, 2026.Financial and operating highlights for the quarter ended September 30,
NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. ("DaVita" or the "Company") (NYSE:DVA). Such investors are advised to contact Danielle
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. ("DaVita" or the "Company") (NYSE:DVA). Such investors are advised to contact
Nearly 1,000 people screened in Houston and Los Angeles, with a majority showing signs of elevated chronic disease riskDENVER, Oct. 27, 2026 /PRNewswire/ -- Millions of Americans are living with chronic disease and
DENVER, Oct. 20, 2026 /PRNewswire/ -- DaVita today issued the following statement in response to the U.S. Department of Health and Human Services' Kidney Care National Plan and related remarks regarding the future
DENVER, Oct. 19, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2026, at 5:00 p.m. Eastern Time.
Patients encouraged to confirm treatment schedules, prepare emergency supplies and contact DaVita for assistanceDENVER, Oct. 8, 2026 /PRNewswire/ -- As Hurricane Isaias approaches the Gulf Coast and southeastern United
SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its
More than 10,000 members will get added support aimed at delaying or preventing dialysis and reducing hospitalizationsDENVER, Aug. 25, 2026 /PRNewswire/ -- DaVita today announced a new value-based care agreement to
